Upcoming MCK earnings date and every past earnings report, with free AI analysis of each 10-K and 10-Q straight from SEC EDGAR filings.
November 3, 2026
McKesson is scheduled to report earnings on this date according to earnings-calendar data from Finnhub and Financial Modeling Prep. Dates can change until the company officially confirms them.
McKesson's Q1 FY2027 revenue grew 8% due to pharmaceutical and specialty sales, but earnings per share fell 18% as a $293 million noncontrolling interest…
McKesson (MCK) delivered a strong fiscal year 2026, with revenue surging 12.4% to $403.4B and net income jumping 44.5% to $4.76B, driven by operating leverage…
MCK reported strong financial performance in Q3 FY2026, with significant increases in revenue, operating income, and net income, despite ongoing cost pressures.
McKesson (MCK) is scheduled to report earnings on November 3, 2026, according to Finnhub's earnings calendar. Dates can change until the company officially confirms them.
McKesson's most recent earnings report was its Q1 FY2027 10-Q, filed with the SEC on August 5, 2026.
EarningsLens publishes free AI analysis of every MCK 10-K and 10-Q filing. The latest covers Q1 FY2027 — open it from the report history on this page.
Like all U.S.-listed public companies, McKesson reports four times a year: three quarterly 10-Q filings and one annual 10-K filing with the SEC.